aluates Reports

$ 0.0

Automative

Global Targeted Drugs for Parkinson's Disease Market Research Report 2024

Published Date: August 2024

Report Code: QYRE-Auto-22Q17830

BUY CHAPTERS

Global Targeted Drugs for Parkinson's Disease Market Research Report 2024

Code: QYRE-Auto-22Q17830

Report

August 2024

Pages:62

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Companies

ACADIA Pharmaceuticals Inc.

KYOWA

Kyowa Kirin

Supernus Pharmaceuticals

UCB

Sumitomo Pharma Co. Ltd.

Targeted Drugs for Parkinson's Disease Market

The global Targeted Drugs for Parkinson's Disease market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.

North American market for Targeted Drugs for Parkinson's Disease is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Targeted Drugs for Parkinson's Disease is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for Targeted Drugs for Parkinson's Disease in Hospital is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of Targeted Drugs for Parkinson's Disease include Acadia Pharmaceuticals Inc., Kyowa Kirin, Supernus Pharmaceuticals, UCB, Sumitomo Pharma Co., Ltd., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Targeted Drugs for Parkinson's Disease, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Targeted Drugs for Parkinson's Disease.

The Targeted Drugs for Parkinson's Disease market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Targeted Drugs for Parkinson's Disease market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Targeted Drugs for Parkinson's Disease companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Targeted Drugs for Parkinson's Disease Market Report

Report Metric	Details
Report Name	Targeted Drugs for Parkinson's Disease Market
Segment by Type	Capsule Patch Other
Segment by Application	Hospital Clinic Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Acadia Pharmaceuticals Inc., Kyowa Kirin, Supernus Pharmaceuticals, UCB, Sumitomo Pharma Co., Ltd.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Targeted Drugs for Parkinson's Disease company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Targeted Drugs for Parkinson's Disease Market report?

Ans: The main players in the Targeted Drugs for Parkinson's Disease Market are Acadia Pharmaceuticals Inc., Kyowa Kirin, Supernus Pharmaceuticals, UCB, Sumitomo Pharma Co., Ltd.

What are the Application segmentation covered in the Targeted Drugs for Parkinson's Disease Market report?

Ans: The Applications covered in the Targeted Drugs for Parkinson's Disease Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Targeted Drugs for Parkinson's Disease Market report?

Ans: The Types covered in the Targeted Drugs for Parkinson's Disease Market report are Capsule, Patch, Other

Recommended Reports

Neurodegenerative Disease Drugs

Targeted & Rare Disease Drugs

Other Neurology Therapeutics

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Targeted Drugs for Parkinson's Disease Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Capsule

1.2.3 Patch

1.2.4 Other

1.3 Market by Application

1.3.1 Global Targeted Drugs for Parkinson's Disease Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Targeted Drugs for Parkinson's Disease Market Perspective (2019-2030)

2.2 Global Targeted Drugs for Parkinson's Disease Growth Trends by Region

2.2.1 Global Targeted Drugs for Parkinson's Disease Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Targeted Drugs for Parkinson's Disease Historic Market Size by Region (2019-2024)

2.2.3 Targeted Drugs for Parkinson's Disease Forecasted Market Size by Region (2025-2030)

2.3 Targeted Drugs for Parkinson's Disease Market Dynamics

2.3.1 Targeted Drugs for Parkinson's Disease Industry Trends

2.3.2 Targeted Drugs for Parkinson's Disease Market Drivers

2.3.3 Targeted Drugs for Parkinson's Disease Market Challenges

2.3.4 Targeted Drugs for Parkinson's Disease Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Targeted Drugs for Parkinson's Disease Players by Revenue

3.1.1 Global Top Targeted Drugs for Parkinson's Disease Players by Revenue (2019-2024)

3.1.2 Global Targeted Drugs for Parkinson's Disease Revenue Market Share by Players (2019-2024)

3.2 Global Targeted Drugs for Parkinson's Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Targeted Drugs for Parkinson's Disease Revenue

3.4 Global Targeted Drugs for Parkinson's Disease Market Concentration Ratio

3.4.1 Global Targeted Drugs for Parkinson's Disease Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Targeted Drugs for Parkinson's Disease Revenue in 2023

3.5 Global Key Players of Targeted Drugs for Parkinson's Disease Head office and Area Served

3.6 Global Key Players of Targeted Drugs for Parkinson's Disease, Product and Application

3.7 Global Key Players of Targeted Drugs for Parkinson's Disease, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Targeted Drugs for Parkinson's Disease Breakdown Data by Type

4.1 Global Targeted Drugs for Parkinson's Disease Historic Market Size by Type (2019-2024)

4.2 Global Targeted Drugs for Parkinson's Disease Forecasted Market Size by Type (2025-2030)

5 Targeted Drugs for Parkinson's Disease Breakdown Data by Application

5.1 Global Targeted Drugs for Parkinson's Disease Historic Market Size by Application (2019-2024)

5.2 Global Targeted Drugs for Parkinson's Disease Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Targeted Drugs for Parkinson's Disease Market Size (2019-2030)

6.2 North America Targeted Drugs for Parkinson's Disease Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Targeted Drugs for Parkinson's Disease Market Size by Country (2019-2024)

6.4 North America Targeted Drugs for Parkinson's Disease Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Targeted Drugs for Parkinson's Disease Market Size (2019-2030)

7.2 Europe Targeted Drugs for Parkinson's Disease Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Targeted Drugs for Parkinson's Disease Market Size by Country (2019-2024)

7.4 Europe Targeted Drugs for Parkinson's Disease Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Targeted Drugs for Parkinson's Disease Market Size (2019-2030)

8.2 Asia-Pacific Targeted Drugs for Parkinson's Disease Market Growth Rate by Country: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Targeted Drugs for Parkinson's Disease Market Size by Region (2019-2024)

8.4 Asia-Pacific Targeted Drugs for Parkinson's Disease Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Targeted Drugs for Parkinson's Disease Market Size (2019-2030)

9.2 Latin America Targeted Drugs for Parkinson's Disease Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Targeted Drugs for Parkinson's Disease Market Size by Country (2019-2024)

9.4 Latin America Targeted Drugs for Parkinson's Disease Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Targeted Drugs for Parkinson's Disease Market Size (2019-2030)

10.2 Middle East & Africa Targeted Drugs for Parkinson's Disease Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Targeted Drugs for Parkinson's Disease Market Size by Country (2019-2024)

10.4 Middle East & Africa Targeted Drugs for Parkinson's Disease Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Acadia Pharmaceuticals Inc.

11.1.1 Acadia Pharmaceuticals Inc. Company Details

11.1.2 Acadia Pharmaceuticals Inc. Business Overview

11.1.3 Acadia Pharmaceuticals Inc. Targeted Drugs for Parkinson's Disease Introduction

11.1.4 Acadia Pharmaceuticals Inc. Revenue in Targeted Drugs for Parkinson's Disease Business (2019-2024)

11.1.5 Acadia Pharmaceuticals Inc. Recent Development

11.2 Kyowa Kirin

11.2.1 Kyowa Kirin Company Details

11.2.2 Kyowa Kirin Business Overview

11.2.3 Kyowa Kirin Targeted Drugs for Parkinson's Disease Introduction

11.2.4 Kyowa Kirin Revenue in Targeted Drugs for Parkinson's Disease Business (2019-2024)

11.2.5 Kyowa Kirin Recent Development

11.3 Supernus Pharmaceuticals

11.3.1 Supernus Pharmaceuticals Company Details

11.3.2 Supernus Pharmaceuticals Business Overview

11.3.3 Supernus Pharmaceuticals Targeted Drugs for Parkinson's Disease Introduction

11.3.4 Supernus Pharmaceuticals Revenue in Targeted Drugs for Parkinson's Disease Business (2019-2024)

11.3.5 Supernus Pharmaceuticals Recent Development

11.4 UCB

11.4.1 UCB Company Details

11.4.2 UCB Business Overview

11.4.3 UCB Targeted Drugs for Parkinson's Disease Introduction

11.4.4 UCB Revenue in Targeted Drugs for Parkinson's Disease Business (2019-2024)

11.4.5 UCB Recent Development

11.5 Sumitomo Pharma Co., Ltd.

11.5.1 Sumitomo Pharma Co., Ltd. Company Details

11.5.2 Sumitomo Pharma Co., Ltd. Business Overview

11.5.3 Sumitomo Pharma Co., Ltd. Targeted Drugs for Parkinson's Disease Introduction

11.5.4 Sumitomo Pharma Co., Ltd. Revenue in Targeted Drugs for Parkinson's Disease Business (2019-2024)

11.5.5 Sumitomo Pharma Co., Ltd. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Companies

ACADIA Pharmaceuticals Inc.

KYOWA

Kyowa Kirin

Supernus Pharmaceuticals

UCB

Sumitomo Pharma Co. Ltd.

List of Tables

Table 1. Global Targeted Drugs for Parkinson's Disease Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Capsule

Table 3. Key Players of Patch

Table 4. Key Players of Other

Table 5. Global Targeted Drugs for Parkinson's Disease Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Targeted Drugs for Parkinson's Disease Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Targeted Drugs for Parkinson's Disease Market Size by Region (2019-2024) & (US$ Million)

Table 8. Global Targeted Drugs for Parkinson's Disease Market Share by Region (2019-2024)

Table 9. Global Targeted Drugs for Parkinson's Disease Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 10. Global Targeted Drugs for Parkinson's Disease Market Share by Region (2025-2030)

Table 11. Targeted Drugs for Parkinson's Disease Market Trends

Table 12. Targeted Drugs for Parkinson's Disease Market Drivers

Table 13. Targeted Drugs for Parkinson's Disease Market Challenges

Table 14. Targeted Drugs for Parkinson's Disease Market Restraints

Table 15. Global Targeted Drugs for Parkinson's Disease Revenue by Players (2019-2024) & (US$ Million)

Table 16. Global Targeted Drugs for Parkinson's Disease Market Share by Players (2019-2024)

Table 17. Global Top Targeted Drugs for Parkinson's Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeted Drugs for Parkinson's Disease as of 2023)

Table 18. Ranking of Global Top Targeted Drugs for Parkinson's Disease Companies by Revenue (US$ Million) in 2023

Table 19. Global 5 Largest Players Market Share by Targeted Drugs for Parkinson's Disease Revenue (CR5 and HHI) & (2019-2024)

Table 20. Global Key Players of Targeted Drugs for Parkinson's Disease, Headquarters and Area Served

Table 21. Global Key Players of Targeted Drugs for Parkinson's Disease, Product and Application

Table 22. Global Key Players of Targeted Drugs for Parkinson's Disease, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Targeted Drugs for Parkinson's Disease Market Size by Type (2019-2024) & (US$ Million)

Table 25. Global Targeted Drugs for Parkinson's Disease Revenue Market Share by Type (2019-2024)

Table 26. Global Targeted Drugs for Parkinson's Disease Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 27. Global Targeted Drugs for Parkinson's Disease Revenue Market Share by Type (2025-2030)

Table 28. Global Targeted Drugs for Parkinson's Disease Market Size by Application (2019-2024) & (US$ Million)

Table 29. Global Targeted Drugs for Parkinson's Disease Revenue Market Share by Application (2019-2024)

Table 30. Global Targeted Drugs for Parkinson's Disease Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 31. Global Targeted Drugs for Parkinson's Disease Revenue Market Share by Application (2025-2030)

Table 32. North America Targeted Drugs for Parkinson's Disease Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 33. North America Targeted Drugs for Parkinson's Disease Market Size by Country (2019-2024) & (US$ Million)

Table 34. North America Targeted Drugs for Parkinson's Disease Market Size by Country (2025-2030) & (US$ Million)

Table 35. Europe Targeted Drugs for Parkinson's Disease Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. Europe Targeted Drugs for Parkinson's Disease Market Size by Country (2019-2024) & (US$ Million)

Table 37. Europe Targeted Drugs for Parkinson's Disease Market Size by Country (2025-2030) & (US$ Million)

Table 38. Asia-Pacific Targeted Drugs for Parkinson's Disease Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 39. Asia-Pacific Targeted Drugs for Parkinson's Disease Market Size by Region (2019-2024) & (US$ Million)

Table 40. Asia-Pacific Targeted Drugs for Parkinson's Disease Market Size by Region (2025-2030) & (US$ Million)

Table 41. Latin America Targeted Drugs for Parkinson's Disease Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 42. Latin America Targeted Drugs for Parkinson's Disease Market Size by Country (2019-2024) & (US$ Million)

Table 43. Latin America Targeted Drugs for Parkinson's Disease Market Size by Country (2025-2030) & (US$ Million)

Table 44. Middle East & Africa Targeted Drugs for Parkinson's Disease Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Middle East & Africa Targeted Drugs for Parkinson's Disease Market Size by Country (2019-2024) & (US$ Million)

Table 46. Middle East & Africa Targeted Drugs for Parkinson's Disease Market Size by Country (2025-2030) & (US$ Million)

Table 47. Acadia Pharmaceuticals Inc. Company Details

Table 48. Acadia Pharmaceuticals Inc. Business Overview

Table 49. Acadia Pharmaceuticals Inc. Targeted Drugs for Parkinson's Disease Product

Table 50. Acadia Pharmaceuticals Inc. Revenue in Targeted Drugs for Parkinson's Disease Business (2019-2024) & (US$ Million)

Table 51. Acadia Pharmaceuticals Inc. Recent Development

Table 52. Kyowa Kirin Company Details

Table 53. Kyowa Kirin Business Overview

Table 54. Kyowa Kirin Targeted Drugs for Parkinson's Disease Product

Table 55. Kyowa Kirin Revenue in Targeted Drugs for Parkinson's Disease Business (2019-2024) & (US$ Million)

Table 56. Kyowa Kirin Recent Development

Table 57. Supernus Pharmaceuticals Company Details

Table 58. Supernus Pharmaceuticals Business Overview

Table 59. Supernus Pharmaceuticals Targeted Drugs for Parkinson's Disease Product

Table 60. Supernus Pharmaceuticals Revenue in Targeted Drugs for Parkinson's Disease Business (2019-2024) & (US$ Million)

Table 61. Supernus Pharmaceuticals Recent Development

Table 62. UCB Company Details

Table 63. UCB Business Overview

Table 64. UCB Targeted Drugs for Parkinson's Disease Product

Table 65. UCB Revenue in Targeted Drugs for Parkinson's Disease Business (2019-2024) & (US$ Million)

Table 66. UCB Recent Development

Table 67. Sumitomo Pharma Co., Ltd. Company Details

Table 68. Sumitomo Pharma Co., Ltd. Business Overview

Table 69. Sumitomo Pharma Co., Ltd. Targeted Drugs for Parkinson's Disease Product

Table 70. Sumitomo Pharma Co., Ltd. Revenue in Targeted Drugs for Parkinson's Disease Business (2019-2024) & (US$ Million)

Table 71. Sumitomo Pharma Co., Ltd. Recent Development

Table 72. Research Programs/Design for This Report

Table 73. Key Data Information from Secondary Sources

Table 74. Key Data Information from Primary Sources

Table 75. Authors List of This Report

List of Figures

Figure 1. Targeted Drugs for Parkinson's Disease Picture

Figure 2. Global Targeted Drugs for Parkinson's Disease Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Targeted Drugs for Parkinson's Disease Market Share by Type: 2023 VS 2030

Figure 4. Capsule Features

Figure 5. Patch Features

Figure 6. Other Features

Figure 7. Global Targeted Drugs for Parkinson's Disease Market Size by Application (2024-2030) & (US$ Million)

Figure 8. Global Targeted Drugs for Parkinson's Disease Market Share by Application: 2023 VS 2030

Figure 9. Hospital Case Studies

Figure 10. Clinic Case Studies

Figure 11. Other Case Studies

Figure 12. Targeted Drugs for Parkinson's Disease Report Years Considered

Figure 13. Global Targeted Drugs for Parkinson's Disease Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 14. Global Targeted Drugs for Parkinson's Disease Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Targeted Drugs for Parkinson's Disease Market Share by Region: 2023 VS 2030

Figure 16. Global Targeted Drugs for Parkinson's Disease Market Share by Players in 2023

Figure 17. Global Top Targeted Drugs for Parkinson's Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeted Drugs for Parkinson's Disease as of 2023)

Figure 18. The Top 10 and 5 Players Market Share by Targeted Drugs for Parkinson's Disease Revenue in 2023

Figure 19. North America Targeted Drugs for Parkinson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. North America Targeted Drugs for Parkinson's Disease Market Share by Country (2019-2030)

Figure 21. United States Targeted Drugs for Parkinson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Canada Targeted Drugs for Parkinson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Targeted Drugs for Parkinson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Targeted Drugs for Parkinson's Disease Market Share by Country (2019-2030)

Figure 25. Germany Targeted Drugs for Parkinson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. France Targeted Drugs for Parkinson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. U.K. Targeted Drugs for Parkinson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Italy Targeted Drugs for Parkinson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Russia Targeted Drugs for Parkinson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Nordic Countries Targeted Drugs for Parkinson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Targeted Drugs for Parkinson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific Targeted Drugs for Parkinson's Disease Market Share by Region (2019-2030)

Figure 33. China Targeted Drugs for Parkinson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Japan Targeted Drugs for Parkinson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. South Korea Targeted Drugs for Parkinson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Southeast Asia Targeted Drugs for Parkinson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. India Targeted Drugs for Parkinson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Australia Targeted Drugs for Parkinson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Targeted Drugs for Parkinson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America Targeted Drugs for Parkinson's Disease Market Share by Country (2019-2030)

Figure 41. Mexico Targeted Drugs for Parkinson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Brazil Targeted Drugs for Parkinson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Targeted Drugs for Parkinson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa Targeted Drugs for Parkinson's Disease Market Share by Country (2019-2030)

Figure 45. Turkey Targeted Drugs for Parkinson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Saudi Arabia Targeted Drugs for Parkinson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. UAE Targeted Drugs for Parkinson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Acadia Pharmaceuticals Inc. Revenue Growth Rate in Targeted Drugs for Parkinson's Disease Business (2019-2024)

Figure 49. Kyowa Kirin Revenue Growth Rate in Targeted Drugs for Parkinson's Disease Business (2019-2024)

Figure 50. Supernus Pharmaceuticals Revenue Growth Rate in Targeted Drugs for Parkinson's Disease Business (2019-2024)

Figure 51. UCB Revenue Growth Rate in Targeted Drugs for Parkinson's Disease Business (2019-2024)

Figure 52. Sumitomo Pharma Co., Ltd. Revenue Growth Rate in Targeted Drugs for Parkinson's Disease Business (2019-2024)

Figure 53. Bottom-up and Top-down Approaches for This Report

Figure 54. Data Triangulation

Figure 55. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Targeted Drugs for Alzheimer s Disease Market Research Report 2024

Global Parkinson Treatment Drug Market Research Report 2025

Global Targeted Drugs for Huntington s Disease Market Research Report 2024

Global Targeted Drugs for Multiple Sclerosis Market Research Report 2024

Global Neurodegenerative Disorder Therapeutics Market Research Report 2024

Global Anti Parkinson Drugs Market Insights Forecast to 2030

Global Targeted Delivery Drugs Market Research Report 2024

Global Deep Brain Stimulation and Service for Parkinson s Disease Market Research Report 2024

Global Neurodegenerative Disease Treatment Market Research Report 2024

Neurodegenerative Diseases Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Targeted Protein Degradation Drug Market Research Report 2024

Global Cardiometabolic Disease Drug Market Research Report 2024

Global Dopamine Antagonist Market Research Report 2024

Global Neurological Biomarkers for Alzheimer s and Parkinson s Diseases Market Research Report 2025

Global Pet Cancer Targeted Drug Market Research Report 2024

Global Parkinson Disease Drug Market Insights Forecast to 2030

Global Gadoteridol Market Research Report 2025

Targeted Radionuclide Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Dopamine Receptor Antagonist Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions